Back To Search Results

Prof Foo Keong Tatt

MBBS, FRCS (Edin), FAMS, Clinical Professor

Emeritus Consultant

Specialty: Urology

Sub-specialties: Benign Prostate Diseases

Clinical Appointments

Emeritus Consultant Urology Singapore General Hospital
Emeritus Consultant Division of Surgery ＆ Surgical Oncology National Cancer Centre Singapore

Profile

Prof Foo is currently an Emeritus Consultant and Advisor Department of Urology at the Singapore General Hospital having served as the Head of Department from 1988 to 2001.

He is a Clinical Professor, National University of Singapore, and an Adjunct Professor with Duke-NUS Medical School.

He is in the Board of Examiners for MBBS as well as M Med (Surgery) Degree and member of the Residency Advisory Committee (RAC) for Urology, under the Specialist Accreditation Board, Singapore having served as Chairman (STC Urology) previously.

He was conferred the honorary member of the Malaysian Urological Association in 1999, the Honorary member of the Singapore Medical Association in 2007, Honorary Member Chinese Urological Association in 2010 and Honorary Fellow Sri Lankan Association of Urological Surgeon in 2011. He was given the Wu Jieping Medical Foundation (China) trophy for his contributions to Urology, in 2000. He was accorded the Lifetime Achieving Award by World Chinese Urological Society in May 2008, Carl Storze Life Time Achievement award by the Endourological Society in Dec 2008 and SIU Distinguished Career Award: Societe Internationale d’Urologie in 2009. He was awarded the Distinguished Golden Achievement Award under GCEO Excellence Awards in 2011.

He was the Visiting Professor to Peking University in 2000 and, Fudan University Shanghai April 2007. He was the Dr Virendas Desai Visiting Professor 2007, to Muljibhai Patel Urological Hospital, Nadiad Gujarat, India. He was appointed Honorary Chief Consultant, Xiamen First Hospital, Xiamen, China Oct 2005.

He was awarded the Public Administrative Medal (Silver) in 2001 by the President of Singapore.

He is the Founder President of the Singapore Urological Association (President 1986 to 1988) and currently member, Board of Trustees for the Association, having served as Chairman previously.

He was the Vice-Chairman for the 5th International Consultation on BPH in Paris, July 2000 and was a member of the Steering Committee for the International Consultation on Urological Diseases (ICUD) (2000 to 2006).

He was the Secretary-General to the Urological Association of Asia from 1998 to 2006, Director of Asian School of Urology from 2006 to 2010 and currently is the Honorary Executive Director of the Urological Association of Asia (UAA) since 2006.

Education

Professional Appointments and Committee Memberships

Clinical Professor (NUS)
Adjunct Professor (Duke-NUS, GMS)

Awards

Research Interests

Publications

LS Lee, HG Sim, KB Lim, D Wang, KT FOO; Intravesical prostatic protrusion predicts clinical progression of benign prostatic enlargement in patients receiving medical treatment; IJU 2010; 17: 69-74
KT FOO; Decision making in the management of benign prostatic enlargement and the role of transabdominal ultrasound; International Journal of Urology 2010; 17: 974-979
D Wang, KT FOO; Staging of Benign Prostate Hyperplasia is Helpful in Patients with Lower Urinary; Tract Symptoms Suggestive of Benign Prostate Hyperplasia; Ann Acad Med Singapore 2010; 39:798-802
Zhang KY, Xing JC, Chen BS, Liu CX, Lau HW, Sim HG, KT FOO; Bipolar plasmakinetic transurethral resection of the prostate vs. transurethral enucleation and resection of the prostate: pre- postoperative comparison of parameters used in assessing benign prostatic enlargement; Singapore Med J 2011; 52(10): 747-751
KT FOO; The Philosophy of Balance: The Art of Healing; Ann Acad Med Singapore Feb 2012; 41(2); 87-90
KT FOO, The Natural History of BPH and the Rationale for Various Modalities of Treatment, Chapter 2, Pg. 13-32, 2012; Benign Prostatic Hyperplasia. Manickam Ramalingam and David M. Albala. 2012 Macmillan Medical Communications
KT FOO, CX LIU; Transurethral Enucleation and Resection of Prostate; Chapter 21, Pg. 245-253, 2012; Benign Prostatic Hyperplasia. Manickam Ramalingam and David M. Albala. 2012 Macmillan Medical Communications
KB Lim, H Ho, KT Foo, M Wong, S Fook. Comparison of intravesical prostatic protrusion, prostate volume and serum prostatic specific antigen in the evaluation of bladder outlet obstruction. IJU 2006; 13: 1509-1513
H Nose, KT Foo, KB Lim, Y Teruhiko, O Hideo. Accuracy of two noninvasive methods of diagnosing bladder outlet obstruction using ultrasonography: intravesical prostatic protrusion and velocity-flow video urodynamicsUrology 2005; 65: 493-497
SJ Chia, CT Heng, SP Chan, KT Foo. Correlation of intravesical prostatic protrusion with bladder outlet obstruction. British Journal of Urology International 2003; 91: 371-374
YH Tan, KT Foo. Intravesical Prostatic Protrusion predicts the outcome of a trial without catheter following acute urine retention. Jr of Urol 2003; 170: 2339-2341
KT Foo, KB Lim, YH Tan, E Gan, SJ Chia. Intravesical prostatic protrusion predicts the natural history of benign prostateic hyperplasia. Journal of Urology 2003; 169(4) Supp: 366
K T Foo, KH Tung, EC Tan, EPC Tock. Carcinoma In-Situ of the Urinary Bladder - The Singapore Experience. Annals, Academy of Medicine, Singapore 1998; 17(1): 152-155
KT Foo. Current Assessment and Proposed Staging of Patients with Benign Prostatic Hyperplasia. Annals, Academy of Medicine, Singapore 1995; 24(4): 648-651
K T Foo. Third Chapter of Surgeons Lecture: “Revolution in Urology and its Evolution in Singapore. Annals, Academy of Medicine, Singapore 1993; 22(2): 261-266
KT Foo, EC Tan, KH Tung, EPC Tock. Intravesical Chemotherapy for Superficial Carcinoma of the Bladder. SMJ 1991; 32: 420-422
KT Foo, KH Tung, EC Tan, CT Liu, WC Foong. The Pattern Of Urinary Stone Disease in a Surgical Department in Singapore. Ed. Ryall Et Al. Publ. Churchill Livingstone 1984